These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1339 related articles for article (PubMed ID: 34351057)

  • 21. COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications.
    Zidan A; Noureldin A; Kumar SA; Elsebaie A; Othman M
    Semin Thromb Hemost; 2023 Feb; 49(1):9-14. PubMed ID: 36603593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines.
    Hwang J; Lee SB; Lee SW; Lee MH; Koyanagi A; Jacob L; Tizaoui K; Yon DK; Shin JI; Smith L
    J Autoimmun; 2021 Aug; 122():102681. PubMed ID: 34139631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative analysis of ChAdOx1 nCoV-19 and Ad26.COV2.S SARS-CoV-2 vector vaccines.
    Michalik S; Siegerist F; Palankar R; Franzke K; Schindler M; Reder A; Seifert U; Cammann C; Wesche J; Steil L; Hentschker C; Gesell-Salazar M; Reisinger E; Beer M; Endlich N; Greinacher A; Völker U
    Haematologica; 2022 Apr; 107(4):947-957. PubMed ID: 35045692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination.
    Lee AYY; Al Moosawi M; Peterson EA; McCracken RK; Wong SKW; Nicolson H; Chan V; Smith T; Wong MP; Lee LJ; Griffiths C; Rahal B; Parkin S; Afra K; Ambler K; Chen LYC; Field TS; Lindsay HC; Lavoie M; Li C; Migneault D; Naus M; Piszczek J; Rahmani P; Sreenivasan G; Wan T; Yee A; Zypchen L; Sweet D
    Blood Adv; 2022 Jun; 6(11):3315-3320. PubMed ID: 35201292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A probable case of vaccine-induced immune thrombotic thrombocytopenia secondary to Pfizer Comirnaty COVID-19 vaccine.
    Goh Cy C; Teng Keat C; Su Kien C; Ai Sim G
    J R Coll Physicians Edinb; 2022 Jun; 52(2):113-116. PubMed ID: 36146992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines.
    Long B; Bridwell R; Gottlieb M
    Am J Emerg Med; 2021 Nov; 49():58-61. PubMed ID: 34062319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding vaccine-induced thrombotic thrombocytopenia (VITT).
    Dix C; McFadyen J; Huang A; Chunilal S; Chen V; Tran H
    Intern Med J; 2022 May; 52(5):717-723. PubMed ID: 35446471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia.
    Greinacher A; Selleng K; Palankar R; Wesche J; Handtke S; Wolff M; Aurich K; Lalk M; Methling K; Völker U; Hentschker C; Michalik S; Steil L; Reder A; Schönborn L; Beer M; Franzke K; Büttner A; Fehse B; Stavrou EX; Rangaswamy C; Mailer RK; Englert H; Frye M; Thiele T; Kochanek S; Krutzke L; Siegerist F; Endlich N; Warkentin TE; Renné T
    Blood; 2021 Dec; 138(22):2256-2268. PubMed ID: 34587242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.
    McGonagle D; De Marco G; Bridgewood C
    J Autoimmun; 2021 Jul; 121():102662. PubMed ID: 34051613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammation and Platelet Activation After COVID-19 Vaccines - Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
    Ostrowski SR; Søgaard OS; Tolstrup M; Stærke NB; Lundgren J; Østergaard L; Hvas AM
    Front Immunol; 2021; 12():779453. PubMed ID: 34887867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aortic thrombosis and acute limb ischemia after ChAdOx1 nCov-19 (Oxford-AstraZeneca) vaccination: a case of vaccine-induced thrombocytopenia and thrombosis (VITT).
    Vierstraete M; Sabbe T
    Acta Chir Belg; 2023 Jun; 123(3):329-332. PubMed ID: 34890294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome in vaccine-induced immune thrombocytopenia and thrombosis.
    Schönborn L; Seck SE; Thiele T; Kaderali L; Hoffmann T; Hlinka A; Lindhoff-Last E; Völker U; Selleng K; Buoninfante A; Cavaleri M; Greinacher A
    J Thromb Haemost; 2023 Sep; 21(9):2519-2527. PubMed ID: 37394120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Most anti-PF4 antibodies in vaccine-induced immune thrombotic thrombocytopenia are transient.
    Schönborn L; Thiele T; Kaderali L; Günther A; Hoffmann T; Seck SE; Selleng K; Greinacher A
    Blood; 2022 Mar; 139(12):1903-1907. PubMed ID: 35113987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kidney Transplantation from a Deceased Donor with COVID-19 Ad26.COV2-S Vaccine-Induced Thrombotic Thrombocytopenia.
    Neretljak I; Jurenec F; Smojver H; Jurekovic Z
    Am J Case Rep; 2023 Apr; 24():e938730. PubMed ID: 37087559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein.
    Greinacher A; Selleng K; Mayerle J; Palankar R; Wesche J; Reiche S; Aebischer A; Warkentin TE; Muenchhoff M; Hellmuth JC; Keppler OT; Duerschmied D; Lother A; Rieg S; Gawaz MP; Mueller KAL; Scheer CS; Napp M; Hahnenkamp K; Lucchese G; Vogelgesang A; Flöel A; Lovreglio P; Stufano A; Marschalek R; Thiele T;
    Blood; 2021 Oct; 138(14):1269-1277. PubMed ID: 34280256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data.
    Cari L; Alhosseini MN; Fiore P; Pierno S; Pacor S; Bergamo A; Sava G; Nocentini G
    J Autoimmun; 2021 Dec; 125():102742. PubMed ID: 34710832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of hepatosplenic thrombosis in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccination.
    Hwang J; Han YJ; Yon DK; Lee SW; Kim BK; Lee SB; Lee MH; Park SH; Koyanagi A; Jacob L; Tizaoui K; Kim SU; Shin JI; Smith L
    Int J Infect Dis; 2022 Mar; 116():114-121. PubMed ID: 34958931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT).
    Gabarin N; Arnold DM; Nazy I; Warkentin TE
    Semin Hematol; 2022 Apr; 59(2):89-96. PubMed ID: 35512906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ischemic Stroke and Vaccine-Induced Immune Thrombotic Thrombocytopenia following COVID-19 Vaccine: A Case Report with Systematic Review of the Literature.
    Cascio Rizzo A; Giussani G; Agostoni EC
    Cerebrovasc Dis; 2022; 51(6):722-734. PubMed ID: 35512656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case report: Vaccine-induced immune thrombotic thrombocytopenia complicated by acute cerebral venous thrombosis and hemorrhage after AstraZeneca vaccines followed by Moderna COVID-19 vaccine booster and surgery.
    Chen QT; Liu Y; Chen YC; Chou CH; Lin YP; Lin YQ; Tsai MC; Chang BK; Ho TH; Lu CC; Sung YF
    Front Neurol; 2022; 13():989730. PubMed ID: 36267879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 67.